Regeneron Pharmaceuticals Inc (REGN)
634.00
-27.00
(-4.08%)
USD |
NASDAQ |
Mar 25, 16:00
635.55
+1.55
(+0.24%)
After-Hours: 20:00
Regeneron Pharmaceuticals Shareholders Equity (Quarterly): 29.35B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen Inc | 5.877B |
| Eli Lilly and Co | 14.19B |
| Merck & Co Inc | 46.31B |
| Pfizer Inc | 88.20B |
| Moderna Inc | 10.90B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 37.76B |
| Total Liabilities (Quarterly) | 8.406B |
| Debt to Equity Ratio | 0.0676 |
| Current Ratio | 4.731 |
| Net Debt Paydown Yield | -0.00% |